<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rapid Dose Therapeutics Corp — News on 6ix</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp</link>
<description>Latest news and press releases for Rapid Dose Therapeutics Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 13 Apr 2026 13:51:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rapid-dose-therapeutics-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683682d078dffbe2df1690a8.webp</url>
<title>Rapid Dose Therapeutics Corp</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp</link>
</image>
<item>
<title>Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-dose-rdtcf-advances-pharmaceutical-manufacturing-expansion-with-burlington-facility-upgrades-targeting-global-medical-markets</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-dose-rdtcf-advances-pharmaceutical-manufacturing-expansion-with-burlington-facility-upgrades-targeting-global-medical-markets</guid>
<pubDate>Mon, 13 Apr 2026 13:51:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - April 13, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company developing oral thin film drug delivery technologies, today announced the initiation of clean room upgrades and facility retrofitting at its Burlington, Ontario manufacturing site, positioning the Company for pharmaceutical expansion, regulatory advancement, and global commercialization opportunities.The upgrade program is...</description>
</item>
<item>
<title>Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-reinforces-strategic-strength-and-global-growth-trajectory</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-reinforces-strategic-strength-and-global-growth-trajectory</guid>
<pubDate>Thu, 26 Mar 2026 13:09:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - March 26, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology leader specializing in innovative oral thin film drug delivery, is pleased to provide shareholders with a strategic update highlighting its continued execution, operational resilience, and expanding global footprint.In an environment marked by global market volatility and geopolitical uncertainty, RDT is uniquely positioned with a...</description>
</item>
<item>
<title>Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-dose-rdtcf-secures-patent-for-quickstriptm-nicotine-oral-film-targeting-dollar38b-smoke-free-nicotine-market-3</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-dose-rdtcf-secures-patent-for-quickstriptm-nicotine-oral-film-targeting-dollar38b-smoke-free-nicotine-market-3</guid>
<pubDate>Thu, 05 Mar 2026 15:08:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - March 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company specializing in oral thin film drug delivery technology, today announced the grant of a key patent for its QuickStrip™ Nicotine Bilayer Oral Film in partnership with Aavishkar Oral Strips.The patent, titled "Nicotine Bilayer Oral Film and Process for Preparation Thereof," has been granted by the Indian Patent Office under Patent Number IN 582202,...</description>
</item>
<item>
<title>Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-advances-cannabinoid-research-and-clinical-evaluation-of-quickstriptm-platform</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-advances-cannabinoid-research-and-clinical-evaluation-of-quickstriptm-platform</guid>
<pubDate>Mon, 23 Feb 2026 11:12:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company focused on innovative drug delivery solutions, today provided an update on its ongoing cannabinoid research initiatives and clinical evaluation of its proprietary QuickStrip™ oral thin film delivery platform.Independent research led by colleagues Dr. Patrick Neary of the Faculty of Kinesiology & Health...</description>
</item>
<item>
<title>Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-begins-trading-162100861</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-begins-trading-162100861</guid>
<pubDate>Wed, 11 Feb 2026 16:21:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - February 11, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that its common shares are now trading in the United States on the OTCQB Venture Market under the ticker symbol RDTCF.The OTCQB listing expands Rapid Dose Therapeutics' presence in the U.S. capital markets by increasing accessibility and visibility for...</description>
</item>
<item>
<title>Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-launches-quickstrip-120000252</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-launches-quickstrip-120000252</guid>
<pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - February 10, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") , a Canadian biotechnology company focused on innovative drug delivery solutions, today announced the commercial launch of its Entourage Phytolab co-branded QuickStrip™ medical cannabis oral thin film in Brazil following regulatory approval for both manufacturing and distribution by Brazil's National Health Regulatory Agency (ANVISA).This milestone...</description>
</item>
<item>
<title>Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-payment-shares-223000929</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-payment-shares-223000929</guid>
<pubDate>Mon, 05 Jan 2026 22:30:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - January 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on December 31, 2025. The Company expects to issue the Common Shares no later than January 15, 2026.The Notes were issued as a...</description>
</item>
<item>
<title>Rapid Dose Completes Extension to Promissory Notes</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-completes-extension-promissory-001900150</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-completes-extension-promissory-001900150</guid>
<pubDate>Tue, 09 Dec 2025 00:19:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it has extended the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. The Notes had a maturity date of November 30, 2025, and the Company extended the maturity date for one year, to November 30, 2026.The Financing was an offering of...</description>
</item>
<item>
<title>Rapid Dose Announces Extension to Promissory Notes</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-extension-promissory-011400684</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-extension-promissory-011400684</guid>
<pubDate>Sat, 29 Nov 2025 01:14:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. The Notes have a maturity date of November 30, 2025, and the Company intends to extend the maturity date for one year, to November 30, 2026.The Financing was an.</description>
</item>
<item>
<title>Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-releases-nicotine-124800531</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-releases-nicotine-124800531</guid>
<pubDate>Mon, 20 Oct 2025 12:48:00 GMT</pubDate>
<description>Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for NicStrip(TM)Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative drug delivery solutions through its QuickStrip™ platform, today issued a comprehensive update on its nicotine strategy, including the extension of its.</description>
</item>
<item>
<title>DEEP Earth Energy Production Corp. Names Christine Hrudka and Wayne Brownlee to its Board of Directors, Appoints John Povhe as CFO and Promotes Ashley Drobot to Vice President of Corporate Development</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/deep-earth-energy-production-corp-names-christine-hrudka-and-wayne-brownlee-to-its-board-of-directors-appoints-john-povhe-as-cfo-and-promotes-ashley-drobot-to-vice-president-of-corporate-development</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/deep-earth-energy-production-corp-names-christine-hrudka-and-wayne-brownlee-to-its-board-of-directors-appoints-john-povhe-as-cfo-and-promotes-ashley-drobot-to-vice-president-of-corporate-development</guid>
<pubDate>Thu, 25 Sep 2025 12:05:00 GMT</pubDate>
<description>DEEP Earth Energy Production Corp. is pleased to announce the appointment of Christine Hrudka and Wayne Brownlee to its Board of Directors, John Povhe to Chief Financial Officer and Ashley Drobot to Vice President of Corporate Development.</description>
</item>
<item>
<title>Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-submits-quickstrip-131600642</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-submits-quickstrip-131600642</guid>
<pubDate>Mon, 04 Aug 2025 13:16:00 GMT</pubDate>
<description>Innovative Oral Nicotine Delivery Technology Targets Safer Alternative for Smokers Burlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company focused on innovative drug delivery technologies, is pleased to announce the submission of a product application to Health Canada for approval of its QuickStrip™ Nicotine products in 1 mg, 2 mg, 3 mg, and 4 mg formats. This regulatory milestone marks a signif</description>
</item>
<item>
<title>Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip(TM) to Combat Opiate Addiction Crisis</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-eco-canadian-110000037</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-eco-canadian-110000037</guid>
<pubDate>Tue, 29 Jul 2025 11:00:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new significant harm reduction initiative aimed at addressing the devastating opioid crisis gripping Canada's First Nations communities. In collaboration with RDT and Eco Canadian Organic Inc. (ECO), a leading expert in opioid replacement therapy, has initiated the Substance Use and Addictions Program (S</description>
</item>
<item>
<title>Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-issuance-123000223</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-issuance-123000223</guid>
<pubDate>Thu, 03 Jul 2025 12:30:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors") to issue common shares (the "Debt Shares") to such Directors in exchange for the cancellation of Director fees owing. Each of the five Directors is owed $10,000 in Director fees for each of the fiscal quarters ended February 28, 2025 and May 31, 2025, for ...</description>
</item>
<item>
<title>Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-completion-share-131000463</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-completion-share-131000463</guid>
<pubDate>Mon, 02 Jun 2025 13:10:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the "Creditors") to issue an aggregate of 1,888,237 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accounts payable (the "Shares for Debt Transaction") in the ...</description>
</item>
<item>
<title>Rapid Dose Announces Proposed Equity Private Placement Financing</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-equity-210300117</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-equity-210300117</guid>
<pubDate>Tue, 27 May 2025 21:03:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - May 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the "Units") at a price of $0.22 per Unit. Each Unit will consist of one (1) common share of the Company (a "Common Share") and one (1) ...</description>
</item>
<item>
<title>Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-aavishkar-oral-220900448</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-aavishkar-oral-220900448</guid>
<pubDate>Mon, 26 May 2025 22:09:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar Oral Strips Pvt. Ltd. These patents cover both dissolvable and non-dissolvable oral nicotine strips-representing a breakthrough in nicotine delivery. These next-gener</description>
</item>
<item>
<title>Rapid Dose Announces Proposed Debt Settlement</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-debt-222700162</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-announces-proposed-debt-222700162</guid>
<pubDate>Fri, 09 May 2025 22:27:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 2,500,000 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accounts payable (the "Shares for Debt Transaction") in the aggregate amount of up to $500,000 (the "Debt") owing to such Creditors. ...</description>
</item>
<item>
<title>Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-provides-clinical-130200662</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-provides-clinical-130200662</guid>
<pubDate>Tue, 08 Apr 2025 13:02:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce an update to the ongoing collaboration project with the Faculty of Kinesiology & Health Studies at the University of Regina on their National Football League (NFL) - funded medical cannabis research project to examine the effects of cannabi</description>
</item>
<item>
<title>Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada</title>
<link>https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-showcase-xylistrip-214000194</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-dose-therapeutics-corp/news/rapid-dose-therapeutics-showcase-xylistrip-214000194</guid>
<pubDate>Thu, 03 Apr 2025 21:40:00 GMT</pubDate>
<description>Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce its participation at major dental tradeshows across Canada to showcase and provide samples of an oral dissolving thin film strip called XyliStrip, powered by QuickStrip.QuickStrip™ is a thin, orally dissolvable film, that can be infused wit</description>
</item>
</channel>
</rss>